People news: Bexion, OraSure Technologies, Ziopharm Oncology

Share this article:

Former FDA commissioner Dr. Lester Crawford, who has worked at a Washington lobbying firm since resigning from the agency in 2005, joined the board of Bexion Pharmaceuticals. Confirmed as commissioner in July 2005, Crawford suddenly resigned from the agency just two months into the role. He later pleaded guilty to lying and violating conflict-of-interest laws.

Device firm OraSure Technologies hired Tony Zezzo as EVP of marketing and sales. He has almost 30 years experience in the diagnostics industry, most recently as VP, North America sales and marketing, Ortho-Clinical Diagnostics.

Ziopharm Oncology hired Dr. Mark Thornton as VP, chief development officer. He is returning to the company after a stint as medical officer for the FDA's Center for Biologics Evaluation and Research.
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.